Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Lau, S.P.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(6)
+
-
Availability
Open access
(6)
+
-
Metadata Only
(1)
+
-
Creation Date
2022
(4)
+
-
2020
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(7)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(7)
+
-
Topic
Immunotherapy
(4)
+
-
Pancreatic cancer
(3)
+
-
CD40
(2)
+
-
Dendritic Cell
(2)
+
-
Vaccines
(2)
+
-
Author
Lau, S.P.
(7)
+
-
Eijck, C.H.J. van
(6)
+
-
Burg, S.H. van der
(5)
+
-
Aerts, J.G.
(3)
+
-
Aerts, J.G.J.V.
(3)
+
-
Dammeijer, F.
(3)
+
-
Klaase, L.
(3)
+
-
Stadhouders, R.
(3)
+
-
Vroman, H.
(3)
+
-
Dumas, J.
(2)
+
-
Gulijk, M. van
(2)
+
-
Hall, T. van
(2)
+
-
Homs, M.Y.V.
(2)
+
-
Land, F.R. van 't
(2)
+
-
Lolkema, M.P.
(2)
+
-
Luider, T.M.
(2)
+
-
Lukkes, M.
(2)
+
-
Mustafa, D.A.M.
(2)
+
-
Nimwegen, M. van
(2)
+
-
Stingl, C.
(2)
+
-
Show more
Language
en
(7)
+
-
Search results
(1 - 7 of 7)
show grid
show list
save search
Dataset from a proteomics analysis of tumor antigens shared between an allogenic tumor cell lysate vaccine and pancreatic tumor tissue
Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer
Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer
Autologous dendritic cells pulsed with allogeneic tumour cell lysate induce tumour-reactive T-cell responses in patients with pancreatic cancer
The PD-1/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes
Dendritic cell vaccination and CD40-agonist combination therapy licenses T cell-dependent antitumor immunity in a pancreatic carcinoma murine model
Rationally combining immunotherapies to improve efficacy of immune checkpoint blockade in solid tumors